[go: up one dir, main page]

DK0758241T3 - Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser - Google Patents

Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser

Info

Publication number
DK0758241T3
DK0758241T3 DK95914495T DK95914495T DK0758241T3 DK 0758241 T3 DK0758241 T3 DK 0758241T3 DK 95914495 T DK95914495 T DK 95914495T DK 95914495 T DK95914495 T DK 95914495T DK 0758241 T3 DK0758241 T3 DK 0758241T3
Authority
DK
Denmark
Prior art keywords
migration
acid derivatives
pct
dentures
bisphosphonic acid
Prior art date
Application number
DK95914495T
Other languages
English (en)
Inventor
Allen E Goodship
John Kenwright
Jonathan Green
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0758241T3 publication Critical patent/DK0758241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Prostheses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
DK95914495T 1994-05-04 1995-04-24 Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser DK0758241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408775A GB9408775D0 (en) 1994-05-04 1994-05-04 Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
PCT/IB1995/000288 WO1995030421A1 (en) 1994-05-04 1995-04-24 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Publications (1)

Publication Number Publication Date
DK0758241T3 true DK0758241T3 (da) 2002-09-23

Family

ID=10754497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914495T DK0758241T3 (da) 1994-05-04 1995-04-24 Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser

Country Status (18)

Country Link
US (1) US5965547A (da)
EP (1) EP0758241B1 (da)
JP (1) JPH09512816A (da)
AT (1) ATE218350T1 (da)
AU (1) AU693541B2 (da)
DE (1) DE69526937T2 (da)
DK (1) DK0758241T3 (da)
ES (1) ES2177642T3 (da)
FI (1) FI118590B (da)
GB (1) GB9408775D0 (da)
HU (1) HUT74984A (da)
IL (1) IL113566A (da)
NO (1) NO310057B1 (da)
NZ (1) NZ283430A (da)
PT (1) PT758241E (da)
TW (1) TW458779B (da)
WO (1) WO1995030421A1 (da)
ZA (1) ZA953537B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
US6137012A (en) 1998-10-13 2000-10-24 E. I. Du Pont De Nemours And Company Phosphole and diphosphole ligands for catalysis
JP3793023B2 (ja) * 1998-12-04 2006-07-05 ロシュ ダイアグノスティックス ゲーエムベーハー 体内プロテーゼの骨統合を促進するためのイバンドロネートの使用
WO2000047214A1 (en) * 1999-02-09 2000-08-17 Sloan-Kettering Institute For Cancer Research Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
CN1319017A (zh) * 1999-08-02 2001-10-24 东丽株式会社 植入物的装入稳定剂
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
SI1591122T1 (sl) 2000-06-20 2013-02-28 Novartis Ag Postopek za aplikacijo bisfosfonatov
ES2247123T7 (es) * 2000-06-20 2013-03-01 Novartis Ag Método para administrar bisfosfonatos
AU2001287260A1 (en) * 2000-07-12 2002-01-21 Ecole Polytechnique Federale De Lausanne (Epfl) Active biocoating for bone implant
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
PT1880744E (pt) * 2002-05-10 2015-02-13 Hoffmann La Roche Ácidos bisfosfónicos para o tratamento e a prevenção da osteoporose
CA2497353C (en) * 2002-09-16 2012-08-28 Novartis Ag Method for preventing or reducing secondary fractures after hip fracture
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
AU2007321109A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
EP1958649A1 (en) * 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
US20100317859A1 (en) * 2007-05-16 2010-12-16 Actavis Group Ptc Ehf Process for the Preparation of Risedronate Sodium
HRP20150496T1 (hr) 2009-09-01 2015-08-14 Duke University, Office Of Licensing And Ventures Bisfosfonatne kompozicije i postupci tretiranja zatajenja srca
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
US9949992B2 (en) 2011-11-16 2018-04-24 Duke University Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
ATE72816T1 (de) * 1986-11-21 1992-03-15 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices

Also Published As

Publication number Publication date
HUT74984A (en) 1997-03-28
ES2177642T3 (es) 2002-12-16
US5965547A (en) 1999-10-12
EP0758241B1 (en) 2002-06-05
DE69526937T2 (de) 2003-01-02
NZ283430A (en) 2000-06-23
FI964332L (fi) 1996-10-28
WO1995030421A1 (en) 1995-11-16
GB9408775D0 (en) 1994-06-22
ZA953537B (en) 1995-11-06
JPH09512816A (ja) 1997-12-22
HU9603042D0 (en) 1997-01-28
AU2146695A (en) 1995-11-29
AU693541B2 (en) 1998-07-02
TW458779B (en) 2001-10-11
NO310057B1 (no) 2001-05-14
IL113566A0 (en) 1995-08-31
IL113566A (en) 2002-05-23
ATE218350T1 (de) 2002-06-15
EP0758241A1 (en) 1997-02-19
NO964486L (no) 1996-10-22
FI118590B (fi) 2008-01-15
NO964486D0 (no) 1996-10-22
DE69526937D1 (de) 2002-07-11
PT758241E (pt) 2002-10-31
FI964332A0 (fi) 1996-10-28

Similar Documents

Publication Publication Date Title
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
IS2034B (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
HUT77944A (hu) Ondansetront tartalmazó, orálisan beadható, folyékony gyógyszerkészítmény
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
BR9509975A (pt) Formulação farmacêutica
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling